New research has uncovered a hidden pathway that allows COVID-19 to infect the immune system and trigger damaging inflammation in the lungs. The study by La Trobe University and WEHI researchers found ...

People with long COVID often report fatigue and other symptoms that make it challenging for them to enjoy life like they once ...

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health ...

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the neurological symptoms of long COVID. The study shows that the SARS-CoV-2 ...

Researchers evaluated whether corticosteroid treatment during acute SARS-CoV-2 infection decreases the risk for long COVID in pediatric patients.

Metformin does not significantly reduce the risk for long COVID at 6 months in low-risk adults with high baseline immunity to the virus.

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...